The Medical Research Institute of New Zealand (MRINZ) has announced that it plans to launch an multi-country clinical study, called Novel START, using New Zealand-based Adherium’s connected inhalers. In addition to New Zealand, other study sites will be in Australia, the United Kingdom, and Italy.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop...
